Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  John Wiley & Sons, Inc.    JW.A

JOHN WILEY & SONS, INC.

(JW.A)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
47.56(c) 47.68(c) 48.08(c) 48.59(c) 46.68(c) Last
176 030 179 402 268 029 271 956 255 606 Volume
-0.46% +0.25% +0.84% +1.06% -3.93% Change
More quotes
Financials (USD)
Sales 2021 1 923 M - -
Net income 2021 146 M - -
Net Debt 2021 - - -
P/E ratio 2021 17,9x
Yield 2021 2,93%
Sales 2022 1 966 M - -
Net income 2022 145 M - -
Net Debt 2022 - - -
P/E ratio 2022 17,8x
Yield 2022 3,02%
Capitalization 2 640 M 2 640 M -
Capi. / Sales 2021 1,37x
Capi. / Sales 2022 1,34x
Nbr of Employees 6 900
Free-Float 52,5%
More Financials
Company
John Wiley & Sons, Inc. provides knowledge and knowledge-enabled services in the areas of research, professional practice and education. The Company operates through three segments: Research, Professional Development and Education. Through the Research segment, the Company provides digital and print scientific, technical, medical and scholarly journals, reference works, books, database services and advertising. The... 
More about the company
Notations Surperformance© of John Wiley & Sons, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about JOHN WILEY & SONS, INC.
01/25JOHN WILEY & SONS : Childhood Cancer Survivors Are Not More Likely to Terminate ..
PU
01/21JOHN WILEY & SONS : Study Finds Especially High Rates of Lupus in Certain Racial..
PU
01/21JOHN WILEY & SONS : Does Where Older US Adults Die Affect Their Wellbeing at the..
PU
01/21JOHN WILEY & SONS : The Important Role of Pharmacists for Older Adults' Health
PU
01/21JOHN WILEY & SONS : Social Influence Matters When It Comes to Following Pandemic..
PU
01/21JOHN WILEY & SONS : Screening Tool May Help Diagnose Mental Disorders in Early P..
PU
01/15JOHN WILEY & SONS : European Academy of Allergy and Clinical Immunology Extends ..
PU
01/14JOHN WILEY & SONS : Esteemed scholars and consultants, and bestselling authors o..
PU
01/14JOHN WILEY & SONS : Wiley Signs Transitional Open Access Agreement with Iowa Sta..
PU
01/12JOHN WILEY & SONS : International bestselling author Alexander Osterwalder joins..
PU
01/06JOHN WILEY & SONS : Does a Mother's Pre-Pregnancy Weight Affect Her Children's F..
PU
01/06JOHN WILEY & SONS : Skin-to Skin Contact with Fathers May Help Newborns After Ca..
PU
01/06JOHN WILEY & SONS : Study Reports Patient-Reported Loss of Smell in 86 Percent o..
PU
01/06JOHN WILEY & SONS : How Effective Are Educational Support Programs for Children ..
PU
01/06JOHN WILEY & SONS : Study Finds Rising Rates of Food Insecurity Among Older Adul..
PU
More news
News in other languages on JOHN WILEY & SONS, INC.
2020JOHN WILEY & SONS, INC. : Veröffentlichung des Halbjahresergebnisses
2020JOHN WILEY & SONS, INC. : publication des résultats semestriels
2020JOHN WILEY & SONS, INC. : Veröffentlichung des Quartalsergebnisses
2020JOHN WILEY & SONS, INC. : publication des résultats trimestriels
2020JOHN WILEY & SONS, INC. : Veröffentlichung des Jahresergebnisses
More news
Chart JOHN WILEY & SONS, INC.
Duration : Period :
John Wiley & Sons, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHN WILEY & SONS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 52,33 $
Last Close Price 46,68 $
Spread / Highest target 28,5%
Spread / Average Target 12,1%
Spread / Lowest Target -3,60%
EPS Revisions
Managers and Directors
NameTitle
Brian A. Napack President, Chief Executive Officer & Director
Jesse C. Wiley Non-Executive Chairman
John Anthony Kritzmacher Chief Financial Officer & Executive VP-Operations
Aref Matin Chief Technology Officer & Executive VP
Raymond W. McDaniel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHN WILEY & SONS, INC.2.23%2 640
S&P GLOBAL INC.-4.20%75 772
RELX PLC4.16%49 079
THOMSON REUTERS CORPORATION1.64%40 416
WOLTERS KLUWER0.96%22 168
EQUIFAX INC.-7.31%21 744